menuclose
Home • Specialist • Associate Professor David Muller

Biography

Associate Professor David Muller is an Interventional Cardiologist located at St Vincent’s Private Hospital Sydney.

A/Prof Muller has a special interest in complex coronary stenting, peripheral vascular intervention, valvular heart disease and transcatheter aortic valve implantation (TAVI).

Associate Professor greatly contributes to research at the University of New South Wales and is also the Director of Director of Cardiac Catheterisation Laboratories at the St Vincent’s Private Hospital Sydney.

CLAIM MY PRE-MADE PROFILE

Procedures & Conditions

Procedures Performed
  • General Cardiology
  • Interventional Cardiology
  • Complex Coronary Stenting
  • Peripheral Vascular Intervention
  • Transcatheter Aortic Valve Implantation (TAVI)
Conditions Treated
  • Valvular Heart Disease
  • Aortic Stenosis

Experience

  • Interventional Cardiologist, Director of Cardiac Catheterisation Laboratories
    St Vincent's Hospital Sydney Present

Memberships

Professional Memberships and Affiliations

  • Fellow of the Royal Australasian College of Physicians (FRACP)

Research & Publications

Publications

1. Namasivayam M; Hayward CS; Muller DWM; Jabbour A; Feneley MP, 2019, ‘Ventricular-Vascular Coupling Ratio Is the Ejection Fraction in Disguise’, Journal of the American Society of Echocardiography, vol. 32, pp. 791, http://dx.doi.org/10.1016/j.echo.2019.01.017

2. Aktuerk D; Jansz P; Shaw M; Muller DWM, 2019, ‘Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart’, Catheterization and Cardiovascular Interventions http://dx.doi.org/10.1002/ccd.28210

3. Sorajja P; Moat N; Badhwar V; Walters D; Paone G; Bethea B; Bae R; Dahle G; Mumtaz M; Grayburn P, 2019, ‘Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients’, Journal of the American College of Cardiology, vol. 73, pp. 1250 – 1260, http://dx.doi.org/10.1016/j.jacc.2018.12.066

4. Nadel J; Subbiah R; Jacobs N; Muller DWM; Gunalingam B, 2019, ‘Successful left atrial appendage closure in a patient with prior patent foramen ovale occlusion’, HeartRhythm Case Reports, vol. 5, pp. 183 – 186, http://dx.doi.org/10.1016/j.hrcr.2018.11.018

5. Muller DWM, 2019, ‘Patient Eligibility for Transcatheter Mitral Valve Replacement: A Small Piece of the Pie ∗’, JACC: Cardiovascular Interventions, vol. 12, pp. 205 – 207, http://dx.doi.org/10.1016/j.jcin.2018.11.025

6. Adlam D; Olson TM; Combaret N; Kovacic JC; Iismaa SE; Al-Hussaini A; O’Byrne MM; Bouajila S; Georges A; Mishra K, 2019, ‘Association of the PHACTR1/EDN1 Genetic Locus With Spontaneous Coronary Artery Dissection’, Journal of the American College of Cardiology, vol. 73, pp. 58 – 66, http://dx.doi.org/10.1016/j.jacc.2018.09.085

7. Spina R; Song N; Kathir K; Muller DWM; Baron D, 2018, ‘Takotsubo cardiomyopathy following unintentionally large subcutaneous adrenaline injection: a case report’, European Heart Journal – Case Reports, vol. 2, http://dx.doi.org/10.1093/ehjcr/yty043

8. Van Zandvoort LJC; Dudek D; Weber-Albers J; Abizaid A; Christiansen EH; Muller DWM; Kochman J; Kołtowski Ł; Lassen JF; Wojdyla R, 2018, ‘Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: The FANTOM II study’, EuroIntervention, vol. 14, pp. E1215 – E1223, http://dx.doi.org/10.4244/EIJ-D-18-00491

9. Namasivayam M; Feneley MP; Hayward CS; Shaw M; Rao S; Jansz P; Muller DWM, 2018, ‘First Evaluation of Acute Left Ventricular Response to Off-Pump Transcatheter Mitral Valve Replacement in High-Risk Patients’, JACC: Cardiovascular Interventions, vol. 11, pp. 2239 – 2240, http://dx.doi.org/10.1016/j.jcin.2018.07.056

10. Muller DWM, 2018, ‘Transcatheter Mitral Valve Replacement: Slow and steady progress’, Journal of Thoracic Disease, vol. 10, pp. S1949 – S1952, http://dx.doi.org/10.21037/jtd.2018.04.154

11. Pasalic L; Wing-Lun E; Lau JK; Campbell H; Pennings GJ; Lau E; Connor D; Liang HP; Muller D; Kritharides L, 2018, ‘Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response’, Journal of Thrombosis and Haemostasis, vol. 16, pp. 1198 – 1210, http://dx.doi.org/10.1111/jth.14008

12. Graham RM; McGrath-Cadell L; Muller DWM; Holloway CJ, 2018, ‘The Mystery and Enigma of Spontaneous Coronary Artery Dissection’, Heart Lung and Circulation, vol. 27, pp. 401 – 405, http://dx.doi.org/10.1016/S1443-9506(18)30060-X

13. Blanke P; Naoum C; Dvir D; Bapat V; Ong K; Muller D; Cheung A; Ye J; Min JK; Piazza N, 2017, ‘Predicting LVOT Obstruction in Transcatheter Mitral Valve Implantation: Concept of the Neo-LVOT’, JACC: Cardiovascular Imaging, vol. 10, pp. 482 – 485, http://dx.doi.org/10.1016/j.jcmg.2016.01.005

14. Worthley SG; Abizaid A; Kirtane AJ; Simon DI; Windecker S; Brar S; Meredith IT; Shetty S; Sinhal A; Almonacid AP, 2017, ‘First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study’, JACC: Cardiovascular Interventions, vol. 10, pp. 147 – 156, http://dx.doi.org/10.1016/j.jcin.2016.10.020

15. Blanke P; Park JK; Grayburn P; Naoum C; Ong K; Kohli K; Norgaard BL; Webb JG; Popma J; Boshell D, 2017, ‘Left ventricular access point determination for a coaxial approach to the mitral annular landing zone in transcatheter mitral valve replacement’, Journal of Cardiovascular Computed Tomography, vol. 11, pp. 281 – 287, http://dx.doi.org/10.1016/j.jcct.2017.04.002

16. Otton JM; Muller DWM, 2017, ‘Apically Tethered Transcatheter Mitral Valve Implantation: Detailed In Vivo Function From Cardiac CT’, JACC: Cardiovascular Interventions, vol. 10, pp. e61 – e63, http://dx.doi.org/10.1016/j.jcin.2016.12.284

17. Muller DWM; Farivar RS; Jansz P; Bae R; Walters D; Clarke A; Grayburn PA; Stoler RC; Dahle G; Rein KA, 2017, ‘Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial’, Journal of the American College of Cardiology, vol. 69, pp. 381 – 391, http://dx.doi.org/10.1016/j.jacc.2016.10.068

18. Spina R; Simon N; Markus R; Muller DWM; Kathir K, 2017, ‘Contrast-induced encephalopathy following cardiac catheterization’, Catheterization and Cardiovascular Interventions, vol. 90, pp. 257 – 268, http://dx.doi.org/10.1002/ccd.26871

19. Spina R; Simon N; Markus R; Muller DWM; Kathir K, 2017, ‘Recurrent contrast-induced encephalopathy following coronary angiography’, Internal Medicine Journal, vol. 47, pp. 221 – 224, http://dx.doi.org/10.1111/imj.13321

20. Naoum C; Leipsic J; Cheung A; Ye J; Bilbey N; Mak G; Berger A; Dvir D; Arepalli C; Grewal J, 2016, ‘Mitral Annular Dimensions and Geometry in Patients with Functional Mitral Regurgitation and Mitral Valve Prolapse Implications for Transcatheter Mitral Valve Implantation’, JACC: Cardiovascular Imaging, vol. 9, pp. 269 – 280, http://dx.doi.org/10.1016/j.jcmg.2015.08.022

21. Spina R; Baron D; Wong S; Hungerford S; Muller DWM, 2016, ‘Severe stress (takotsubo) cardiomyopathy following subarachnoid haemorrhage’, International Journal of Cardiology, vol. 210, pp. 119 – 121, http://dx.doi.org/10.1016/j.ijcard.2016.02.118

22. Muller DWM; Liebetrau C, 2016, ‘Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH)’, EuroIntervention, vol. 12, pp. X35 – X43, http://dx.doi.org/10.4244/EIJV12SXA8

23. Tay E; Muda N; Yap J; Muller DWM; Santoso T; Walters DL; Liu X; Yamen E; Jansz P; Yip J, 2016, ‘The MitraClip Asia-Pacific registry: Differences in outcomes between functional and degenerative mitral regurgitation’, Catheterization and Cardiovascular Interventions, vol. 87, pp. 275 – 281, http://dx.doi.org/10.1002/ccd.26289

24. Spina R; Muller DWM; Jansz P; Gunalingam B, 2016, ‘Nickel hypersensitivity reaction following Amplatzer atrial septal defect occluder device deployment successfully treated by explantation of the device’, International Journal of Cardiology, vol. 223, pp. 242 – 243, http://dx.doi.org/10.1016/j.ijcard.2016.08.112

25. Corbisiero R; Buck DC; Muller D; Bharmi R; Dalal N; Kazemian P, 2016, ‘What is the cost of non-response to cardiac resynchronization therapy? Hospitalizations and healthcare utilization in the CRT-D population’, Journal of Interventional Cardiac Electrophysiology, vol. 47, pp. 189 – 195, http://dx.doi.org/10.1007/s10840-016-0180-z

26. Corbisiero R; Kazemian P; Bharmi R; Shah R; Muller D, 2016, ‘Less with More: Hospitalization Cost and Event Rates with Quadripolar versus Bipolar CRT-D System’, PACE – Pacing and Clinical Electrophysiology, vol. 39, pp. 1038 – 1045, http://dx.doi.org/10.1111/pace.12923

27. Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van Der Heyden J; Lang I; Petrie MC, 2016, ‘A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): A multicentre, open-label, single-arm, phase 1 trial’, The Lancet, vol. 387, pp. 1298 – 1304, http://dx.doi.org/10.1016/S0140-6736(16)00704-2

28. Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M, 2016, ‘One-Year Outcomes after Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure with Preserved Ejection Fraction’, Circulation: Heart Failure, vol. 9, http://dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003662

29. McGrath-Cadell L; McKenzie P; Emmanuel S; Muller DWM; Graham RM; Holloway CJ, 2016, ‘Outcomes of patients with spontaneous coronary artery dissection.’, Open Heart, vol. 3, pp. e000491, http://dx.doi.org/10.1136/openhrt-2016-000491

30. Connor DE; Ly K; Aslam A; Boland J; Low J; Jarvis S; Muller DW; Joseph JE, 2016, ‘Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease’, Platelets, vol. 27, pp. 805 – 811, http://dx.doi.org/10.1080/09537104.2016.1190008

More publications available upon request. 

View More

Presentations

  • Alharbi Y; Otton J; Muller D; Lovell N; Al Abed A; Dokos S, 2018, ‘Left Ventricular Fluid Dynamics Simulation for Transcatheter Mitral Valve Replacement’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Diego, CA, pp. B9 – B9, presented at 30th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Diego, CA, 21 – 25 September 2018
  • Alharbi YS; Lovell NH; Otton J; Muller D; Al Abed A; Dokos S, 2017, ‘Left ventricular patient-specific fluid dynamics simulations for artificial mitral valve placement’, in 9th Australasian Congress on Applied Mechanics, ACAM 2017
  • Alharbi Y; Lovell NH; Otton J; Muller D; Al Abed A; Dokos S, 2017, ‘Image-based fluid dynamics analysis of left ventricle outflow tract pressure gradient after deployment transcatheter mitral valve’, in Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS, pp. 4223 – 4226
  • Pasupati S; Muller DW; Walton T; Walters DL; Worthley SG; Ormiston JA; Whitbourn RJ; Yong G; Meredith IT, 2013, ‘When Is Aortic Regurgitation Important In Transcatheter Aortic Valve Implantation’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. B237 – B237, presented at 25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco, CA, 27 October – 01 November 2013
  • Muller DW; Aroney C; Jansz P; Passage J; Walters D; Yamen E, 2013, ‘Six Month Outcomes of an Initial Cohort of Patients Treated in the Australia and New Zealand (ANZ) MitraClip Registry’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. B214 – B214, presented at 25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco, CA, 27 October – 01 November 2013
  • Spina R; Boland JE; Baron D; Roy P; Muller DW; Gunalingam B, 2013, ‘A Comparison of Angiographic and Transesophageal Measurements of Left Atrial Appendage Dimensions during Catheter-Based Left Atrial Appendage Occlusion: Implications for Sizing and Safety’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. B210 – B210, presented at 25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco, CA, 27 October – 01 November 2013
  • Tay EL; Yap J; Muller DW; Walters DL; Muda MN; Yamen E; Yip JW; Zambahari R; Passage J; Jansz P, 2013, ‘Outcomes from MitraClip Therapy in Functional Compared to Degenerative Mitral Regurgitation: Multi-centre Experience from the MitraClip Asia-Pacific Registry (MARS)’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. B213 – B213, presented at 25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco, CA, 27 October – 01 November 2013
  • Spina R; Roy P; Baron D; Muller DW; Gunalingam B, 2013, ‘Efficacy and Safety of Left Atrial Appendage Occlusion with the Watchman Device without Post-Procedure Oral Anticoagulation.’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. B206 – B206, presented at 25th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco, CA, 27 October – 01 November 2013
  • Meredith I; Walton T; Walters D; Worthley S; Pasaputi S; Ormiston J; Whitbourn R; Yong G; Muller D, 2012, ‘Long-Term Outcomes From The CoreValve Transcatheter Aortic Valve Australia-New Zealand Study’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, Miami, FL, pp. B234 – B234, presented at Transcatheter Cardiovascular Therapeutics (TCT) Symposium, Miami, FL, 22 – 26 October 2012
  • Meredith I; Walton T; Walters D; Ormiston J; Worthley S; Yong G; Whitbourn R; Pasupati S; Muller D, 2011, ‘Twelve-Month Results from the CoreValve Transcatheter Aortic Valve Australia-New Zealand Study’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. B39 – B39, presented at 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, San Francisco, CA, 07 – 11 November 2011
  • Meredith IT; Worthley SG; Walters DL; Whitbourn R; Horrigan M; McClean D; Ormiston J; Wilkins G; Hendriks R; Matsis PP, 2011, ‘Final 5 Year Follow-up from the RESOLUTE First in Man Trial’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. B11 – B11, presented at 23rd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium, San Francisco, CA, 07 – 11 November 2011
  • Ruygrok P; Sievert H; Schoefer J; Grube E; Meier B; Muller D; Greaves S; Edwards M; Wunderlich N, 2009, ‘Safety and Efficacy of the COHEREX FLATSTENT (TM) Patent Foramen Ovale Closure Device: A Multi-center Study’, in AMERICAN JOURNAL OF CARDIOLOGY, EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, San Francisco, CA, pp. 29D – 29D, presented at 21st Annual Transcatheter Cardiovascular Therapeutics Conference, San Francisco, CA, 21 – 25 September 2009
  • Meredith IT; Ormiston J; Whitbourn R; Kay IP; Muller D; Negoita M; Kuntz RE; Fitzgerald PJ, 2008, ‘First -in-Man Study of the Endeavor Zotarolimus-Eluting Stent: Final 5-Year Follow-up’, in AMERICAN JOURNAL OF CARDIOLOGY, EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, Washington, CA, pp. 130I – 131I, presented at 20th Annual Transcatheter Cardiovascular Therapeutics Conference, Washington, CA, 12 – 17 October 2008
  • Min X; Demers P; Muller D; Snell JD; Levine PA; Ostrow EL, 2007, ‘Comparison of P wave durations as assessed with the bipolar and unipolar atrial intracardiac electrograms: Applicability to quickOpt™’, in Computers in Cardiology, pp. 773 – 776
  • Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J, 2007, ‘The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study’, in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Orlando, FL, pp. 591 – 592, presented at 80th Annual Scientific Session of the American-Heart-Association, Orlando, FL, 04 – 07 November 2007
  • Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Ma DD; Tao H; Freund J; Milliken ST; Dodds AJ; Moore JJ, 2007, ‘The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study’, in Circulation, Lippincott Williams & Wilkins, Orlando, Florida, USA, pp. 2669 – 2670, presented at 80th Annual Scientific Session of the American-Heart-Association, Orlando, Florida, USA, 04 – 07 November 2007
  • Hongo Y; Sakurai R; Meredith I; Whitbourn RJ; Ormiston J; Key P; Muller D; Pitney M; Aroney C; Adams M, 2004, ‘Intravascular ultrasound analysis of the new ABT-578 eluting phosphorylcholine-coated stent implantation to de novo human coronary lesions: The ENDEAVOR I trial’, in JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER SCIENCE INC, New Orleans, LA, pp. 85A – 85A, presented at 54th Annual Scientific Session of the American-College-of-Cardiology, New Orleans, LA, 07 – 10 March 2004
  • Faddy S; Boland J; Muller DWM, 2003, ‘Accuracy and reliability of non-invasive cardiac output: The future in cardiology?’, in Computers in Cardiology, pp. 251 – 253
  • Muller DWM, 1997, ‘Restenosis: The potential for gene therapy’, in Asia Pacific Heart Journal, pp. 71
  • Crowe JR; Shapo BM; Stephens DN; Bleam D; Eberle MJ; Wu CC; Muller DWM; Kovatch JA; Lederman RJ; O’Donnell M, 1996, ‘Coronary artery flow imaging with an intraluminal array’, in Proceedings of the IEEE Ultrasonics Symposium, pp. 1481 – 1484
View More